Brevan Howard Capital Management’s ARS Pharmaceuticals SPRY Stock Holding History

Brevan Howard Capital Management’s Portfolio SPRY Stock Details SPRY Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell
2025 Q3	$675K	Buy
2024 Q4	–	Sell
2024 Q3	$477K	Buy